RE SHANXI CENTRAL PHARMACEUTICAL INTERNATIONAL LTD
HTML content
HCCW 1003/2004
IN THE HIGH COURT OF THE
HONG KONG SPECIAL ADMINISTRATIVE REGION
COURT OF FIRST INSTANCE
COMPANIES (WINDING-UP) NO. 1003 OF 2004
____________
| IN THE MATTER of the Companies Ordinance, Chapter 32 | |
| and | |
| IN THE MATTER of SHANXI CENTRAL PHARMACEUTICAL INTERNATIONAL LIMITED (正中藥業國際有限公司) |
____________
Before: Hon Kwan J in Court
Date of Hearing: 28 February 2005
Date of Judgment: 28 February 2005
_______________
J U D G M E N T
_______________
1. This is a petition to wind up Shanxi Central Pharmaceutical International Limited (“the Company”) presented by DBS Bank (Hong Kong) Limited. The Company was incorporated in Bermuda and its shares have been listed in The Stock Exchange of Hong Kong Limited. Trading in the shares has been suspended since July 2003. The Company was placed into the third stage of the delisting process since 10 September 2004 and that means it would have six months to submit a valid resumption proposal by 9 March 2005, otherwise the Company would be delisted.
2. The petitioning debt is in the sum of HK$ 32,407,611.97, being the balance of a judgment debt obtained by the petitioner in HCA No.1108 of 2003 on 23 February 2004. A demand for the debt was served on the principal place of business of the Company on 26 June 2004 and the petition herein was presented on 15 September 2004.
3. On 8 November 2004, I made an order appointing provisional liquidators to the Company on the application of the petitioner, for provisional liquidators to explore a restructuring of the debts and a resumption of trading in the shares of the Company. On 15 November 2004, the petition was adjourned to today for the provisional liquidators to look for potential investors.
4. The provisional liquidators have reported to the court on 25 February 2004. In the very limited time available to them, they have found three interested investors but as it transpired, the resumption proposal of one of them failed to meet the requirements in the Listing Rules, another has stated that it is unable to submit a resumption proposal before the deadline for delisting, and the third has withdrawn negotiations. As matters now stand, there is no potential investor that would be in a position to submitt a valid resumption proposal before the deadline and there is no prospect of formulating a restructuring with the aim of restoring the listing of the shares on the Stock Exchange. In these circumstances, the petitioner seeks a winding-up order today.
5. I order the Company to be wound up and that the provisional liquidators are to continue to act as such until they or some other person are appointed as liquidators, pursuant to section 194(1)(aa) of the Companies Ordinance, Cap. 32. I further order the petitioner’s costs in the petition to be paid out of the assets of the Company, save for the costs of the summons issued by the petitioner on 25 February 2005, as this summons is wholly unnecessary.
| (S Kwan) | |
| Judge of the Court of First Instance | |
| High Court |
Miss Teresa Wu, instructed by Messrs. Wilkinson & Grist, for the Petitioner
The Company, Shanxi Central Pharmaceutical International Limited, absent
Miss Vivian Yeung for the Official Receiver